Sign Up to like & get
recommendations!
1
Published in 2020 at "British Journal of Pharmacology"
DOI: 10.1111/bph.15042
Abstract: Alzheimer's disease (AD) is the most prevalent disease associated with cognitive dysfunction. Current AD therapeutic agents have several gastrointestinal or psychological adverse effects and therefore, novel therapeutic agents with fewer adverse effects must be developed.…
read more here.
Keywords:
maslinic acid;
effect maslinic;
cognitive dysfunction;
cholinergic blockade ... See more keywords